This announcement is a separate document:
荃信生物-B：中國證監會受理本公司H股全流通計劃申請
QYUNS-B: ACCEPTANCE BY THE CSRC OF APPLICATION FOR THECOMPANY'S H SHARE FULL CIRCULATION PLAN
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated